EMA accepts marketing application for trastuzumab and pegfilgrastim
The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim.
The proposed biosimilars...
Merck to present new and updated data of Keytruda to treat breast cancers at 2017 SABC symposium
Merck, known as MSD outside the United States and Canada, announced that new and updated data from six abstracts investigating Keytruda (pembrolizumab), the company’s...
Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a clinical-stage biopharmaceutical company, today announced the presentation of a scientific poster entitled “Selective Inhibitors Suggest Nav1.6 Activity is the...
FDA Approves Amgen’s Repatha® (evolocumab) To Prevent Heart Attack And Stroke
Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha® (evolocumab) as the...
NIH initiates HIV prevention trial of long-acting injectable medication in sexually active women
The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study in southern and...
Portugal researcher to create 3D cancer disease models
The Institution of Engineering and Technology (IET) in the UK has awarded a prize fund to a Portuguese researcher for the creation of reliable...
FDA grants orphan drug status to Shire’s UC treatment SHP647
The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody, SHP647, for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...